ASCO: Data detail Verzenio's flop in prostate cancer as Lilly seeks redemption via radiotherapy

ASCO: Data detail Verzenio's flop in prostate cancer as Lilly seeks redemption via radiotherapy aliu Wed, 05/22/2024 - 16:49